Cancerous disease modifying antibodies
Details for Australian Patent Application No. 2004248865 (hide)
International Classifications
Event Publications
2 February 2006 PCT application entered the National Phase
PCT publication WO2004/112834 Priority application(s): WO2004/112834
21 May 2009 Assignment before Grant
Arius Research, Inc. The application has been assigned to F.Hoffmann-La Roche AG
19 May 2011 Amendment Made
The nature of the amendment is: Amend the divisional details to read 2002226211
21 July 2011 Application Accepted
Published as AU-B-2004248865
17 November 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser